Carlotta Foletti, PhD – www.brainwork.md

17th May 2019

Shedding light on CIDP

https://www.brainwork.md/content/uploads/2019/05/MPR585-Brainwork-AAN-V00-03-20190509-01.jpg 1920 1080 Carlotta Foletti, PhD Carlotta Foletti, PhD https://secure.gravatar.com/avatar/c8bf2814aa3641344dd6e3b11325ad20?s=96&d=mm&r=g 17th May 2019 31st May 2019

While it is the most common chronic autoimmune neuropathy, chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare, acquired peripheral neuropathy characterised by proximal upper and lower limb weakness. CIDP remains…

Carlotta Foletti, PhD
0
0

17th May 2019

Establishing sNfL as an MS Biomarker

https://www.brainwork.md/content/uploads/2019/05/Brainwork-MSBiomarkers.jpg 3300 2200 Carlotta Foletti, PhD Carlotta Foletti, PhD https://secure.gravatar.com/avatar/c8bf2814aa3641344dd6e3b11325ad20?s=96&d=mm&r=g 17th May 2019 17th May 2019

At the ECTRIMS annual congress in October 2018, there was a lot of talk on serum neurofilament light (sNfL) becoming the first blood biomarker predicting neuronal damage caused by neurological…

Carlotta Foletti, PhD
0
0

17th May 2019

News from the ocrelizumab front

https://www.brainwork.md/content/uploads/2019/05/Brainwork-NewsOcrelizumab.jpg 3300 2200 Carlotta Foletti, PhD Carlotta Foletti, PhD https://secure.gravatar.com/avatar/c8bf2814aa3641344dd6e3b11325ad20?s=96&d=mm&r=g 17th May 2019 17th May 2019

In our ongoing coverage of the AAN Annual Meeting in Philadelphia, we are focusing on select posters reporting on studies of ocrelizumab, an intravenous humanised monoclonal antibody that selectively targets…

Carlotta Foletti, PhD
0
0

17th May 2019

Latest advances in migraine therapy

https://www.brainwork.md/content/uploads/2019/05/Brainwork-MigraineTreatment.jpg 3682 2200 Carlotta Foletti, PhD Carlotta Foletti, PhD https://secure.gravatar.com/avatar/c8bf2814aa3641344dd6e3b11325ad20?s=96&d=mm&r=g 17th May 2019 17th May 2019

Migraines are the most common type of primary headache disorders, and triptans – serotonin 5-HT1B/1D receptor agonists originally developed as cranial vasoconstrictors – are the backbone of current acute attack…

Carlotta Foletti, PhD
0
0

16th May 2019

Preventing migraines through diet

https://www.brainwork.md/content/uploads/2019/05/MPR585-Brainwork-AAN-Migraine-Triggers-V00-03-20190514-01.jpg 1920 1080 Carlotta Foletti, PhD Carlotta Foletti, PhD https://secure.gravatar.com/avatar/c8bf2814aa3641344dd6e3b11325ad20?s=96&d=mm&r=g 16th May 2019 17th May 2019

As part of our coverage on the updates in migraine research at the 2019 AAN Annual Meeting, we attended Dr Belinda Savage-Edwards’ presentation – in collaboration with chef Tess Connors…

Carlotta Foletti, PhD
0
0

16th May 2019

An update on chronic migraine diagnosis

https://www.brainwork.md/content/uploads/2019/05/Brainwork-ChronicMigraineDiagnosis.jpg 3300 2200 Carlotta Foletti, PhD Carlotta Foletti, PhD https://secure.gravatar.com/avatar/c8bf2814aa3641344dd6e3b11325ad20?s=96&d=mm&r=g 16th May 2019 17th May 2019

Headache disorders are among the leading causes of years lived with disability, in both men and women.1 Chronic migraines, in particular, are typically estimated to have a global prevalence of…

Carlotta Foletti, PhD
0
0

18th January 2019

Acting fast on atrial fibrillation

https://www.brainwork.md/content/uploads/2019/01/Brainwork-ActingFast.jpg 2800 2100 Carlotta Foletti, PhD Carlotta Foletti, PhD https://secure.gravatar.com/avatar/c8bf2814aa3641344dd6e3b11325ad20?s=96&d=mm&r=g 18th January 2019 1st February 2019

Early detection of atrial fibrillation – the next breakthrough in health and wearable technology? Johnson & Johnson, in collaboration with Apple Inc., just announced plans to investigate the use of…

Carlotta Foletti, PhD
0
0